5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA

Severe illness associated with reported use of synthetic cannabinoids: a public health investigation (Mississippi, 2015)

(2018) Amelia M. Kasper et al.   CLINICAL TOXICOLOGY

Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL-PEGACLONE and detection in human urine samples

(2018) Lukas Mogler et al.   Drug Testing and Analysis

Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA

(2018) Thomas F. Gamage et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Structural characterization of the new synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA

(2017) Michael Bovens et al.   FORENSIC SCIENCE INTERNATIONAL

Identification of MDMB-FUBINACA in commercially available e-liquid formulations sold for use in electronic cigarettes

(2017) Michelle R. Peace et al.   FORENSIC SCIENCE INTERNATIONAL

In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA

(2017) Richard C. Kevin et al.   Forensic Toxicology

Cannabimimetic activities of cumyl carboxamide-type synthetic cannabinoids

(2017) Akiko Asada et al.   Forensic Toxicology

Identification of the Synthetic Cannabinoid 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) in Plant Material and Quantification in Post-Mortem Blood Samples

(2017) Oya Yeter   JOURNAL OF ANALYTICAL TOXICOLOGY

To prohibit or regulate psychoactive substances: has New Zealand got the right approach?

(2017) Shakila B Rizwan et al.   BMJ-British Medical Journal

To prohibit or regulate psychoactive substances: has New Zealand got the right approach?

(2017) Shakila B Rizwan et al.   BMJ-British Medical Journal

Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project

(2016) Maren Hermanns-Clausen et al.   Drug Testing and Analysis

E-cigarettes, Hookah Pens and Vapes: Adolescent and Young Adult Perceptions of Electronic Nicotine Delivery Systems: Table 1.

(2016) Kimberly G. Wagoner et al.   NICOTINE & TOBACCO RESEARCH

Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA

(2015) Ariane Wohlfarth et al.   AAPS Journal

High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes

(2015) X. Diao et al.   CLINICAL CHEMISTRY

Identification and quantification of synthetic cannabinoids in “spice-like” herbal mixtures: update of the German situation for the spring of 2015

(2015) Nico Langer et al.   Forensic Toxicology

Hidden Formaldehyde in E-Cigarette Aerosols

(2015) R. Paul Jensen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adolescents’ and Young Adults’ Perceptions of Electronic Cigarettes for Smoking Cessation: A Focus Group Study

(2015) Deepa R. Camenga et al.   NICOTINE & TOBACCO RESEARCH

E-Cigarettes

(2014) Rachel Grana et al.   CIRCULATION

Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications

(2014) Marisol S. Castaneto et al.   DRUG AND ALCOHOL DEPENDENCE

An Outbreak of Exposure to a Novel Synthetic Cannabinoid

(2014) Andrew A. Monte et al.   NEW ENGLAND JOURNAL OF MEDICINE

First Characterization of AKB-48 Metabolism, a Novel Synthetic Cannabinoid, Using Human Hepatocytes and High-Resolution Mass Spectrometry

(2013) Adarsh S. Gandhi et al.   AAPS Journal

First Metabolic Profile of XLR-11, a Novel Synthetic Cannabinoid, Obtained by Using Human Hepatocytes and High-Resolution Mass Spectrometry

(2013) A. Wohlfarth et al.   CLINICAL CHEMISTRY

Identification and quantification of synthetic cannabinoids in ‘spice-like’ herbal mixtures: A snapshot of the German situation in the autumn of 2012

(2013) Nico Langer et al.   Drug Testing and Analysis

Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism

(2013) Melanie Hutter et al.   JOURNAL OF MASS SPECTROMETRY

Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings

(2012) Maren Hermanns-Clausen et al.   ADDICTION

Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC–MS, NMR analysis and a flash chromatography system

(2012) Bjoern Moosmann et al.   FORENSIC SCIENCE INTERNATIONAL

Synthetic cannabinoid and marijuana exposures reported to poison centers

(2012) MB Forrester et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Analysis of First and Second Generation Legal Highs for Synthetic Cannabinoids and Synthetic Stimulants by Ultra-Performance Liquid Chromatography and Time of Flight Mass Spectrometry

(2012) K. G. Shanks et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Conjugation of Synthetic Cannabinoids JWH-018 and JWH-073, Metabolites by Human UDP-Glucuronosyltransferases

(2011) K. C. Chimalakonda et al.   DRUG METABOLISM AND DISPOSITION